220 Stocks to Sell Today
Free Report for Zacks.com
Visitors Only

Overall, Zacks Rank #5 Strong Sells perform 6X worse than the market. Are any of these portfolio killers lurking among the stocks you're holding or considering? Find out today for free.


No cost, no obligation to buy anything ever.
Privacy Policy
Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
SONIC FOUNDR SOFO
4.40%
SUPPORTCOM I SPRT
3.75%
UNISYS CORP UIS
3.31%
SHORETEL INC SHOR
3.22%
GREEN MOUNTA GMCR
3.13%

Raven Stays at Neutral

by Zacks Equity Research

October 15, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We reiterate our Neutral recommendation on Raven Industries Inc. (RAVN - Analyst Report). We expect the company’s revenues to benefit from the soaring demand for its geo membrane films. But its margins would remain constrained due to increased capital spending and the prevailing drought conditions in the U.S.

Raven, in second-quarter fiscal 2013, reported earnings of 32 cents per share, missing the Zacks Consensus Estimate of 38 cents. Revenues improved 13% year over year to $101.7 million, marginally missing the Zacks Consensus Estimate of $102 million.
Sales and operating income in the Engineered Films segment were at record levels during the quarter, due to the soaring demand for the geo membrane films. The geo membrane films, meant for environmental protection, are experiencing higher demand as customers are keen on protecting water and other environmental resources for a sustainable future. Rising demand for the geo membrane films is expected to boost revenues further moving ahead.
Vista Research, which Raven acquired in January 2012, has a high growth potential. Vista Research has recently signed a new $6 million contract with the U.S. government to support and further explore the applications of its radar technology. Moreover, the company is also focusing on increasing the customer base of Vista both in the domestic and international markets.
In addition, Raven aims at enhancing its product portfolio to increase its market share in the industry. The company introduced many new products in the applied technologies segment and has decided to further invest in product development in this segment in fiscal 2013 to meet the increasing demand of its customers.
However, increased capital spending will pressure margins moving forward. During the first half of fiscal 2013, capital spending increased $6 million. Capital spending is expected to increase to $35 million this year. Moreover, R&D expenses in the Applied Technology and Aerostar division are also projected to increase.
Adding to the woe is the severe drought condition in the U.S which is expected to hinder Raven’s results, pressuring its revenues on the home front.
Our long-term recommendation is in line with the short-term Zacks #3 Rank (Hold).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.